EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

Comparison Of Flunisolide Nasal Spray With Combined Oral Antihistamine And Antileukotriene Therapy In Allergic Rhinitis In Relation To Patients’ Symptoms

Zahra Batool, Ch. M. Bilal Akram, Saad Bin Qamar, Inshaal Khalid, Rubab Akhtar, Farah Arshid

Journal of Rawalpindi Medical College · 30.06.2026 · 30 (2) · 252-257

DOI: 10.37939/jrmc.v30i2.3094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Rawalpindi Medical College, online erschienen am 30.06.2026. Verfasst von Zahra Batool und 5 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare the efficacy of flunisolide nasal spray with combined oral antihistamine and leukotriene receptor inhibitor therapy in improving symptoms among patients with allergic rhinitis (AR).

Methods

This quasi-experimental comparative study was conducted in the Department of Otorhinolaryngology over nine months after ethical approval. A total of 100 adults (18–45 years) with AR were enrolled and divided into two groups (n = 50 each) using a non-probability consecutive sampling method. Group A received oral loratadine (10 mg) plus montelukast (10 mg), whereas Group B received flunisolide nasal spray (100 µg, two puffs per nostril twice daily). Total nasal symptom scores (TNSS) were recorded at baseline, 2 weeks, and 4 weeks after treatment. Data were analysed using SPSS version 23, and the Mann–Whitney U test was applied to compare treatment outcomes using TNSS between both groups, with P ≤ .05 considered significant.

Results

A total of 100 patients (50 per group) were included in the study. Baseline TNSS was comparable between the groups (P = .659). No significant difference was observed at 1st follow-up (P = .979), while at 2nd follow-up, Group B showed a significantly lower TNSS (P < .001). After adjusting for age and baseline TNSS, the results at 2nd follow-up remained significant, favouring flunisolide therapy (B = −0.719, 95% CI: −1.181 to −0.257; P = .003) with a moderate effect size (r=.35).

Conclusion

Flunisolide nasal spray was more effective than combined oral antihistamine–leukotriene therapy and may be preferred as a first-line treatment for AR. Keywords: Allergic rhinitis, Flunisolide, Intranasal corticosteroids, Loratadine, Montelukast, Nasal congestion, Rhinorrhea

Zitieren

APA

Batool, Z., Akram, C. M. B., Qamar, S. B., Khalid, I., Akhtar, R., & Arshid, F. (2026). Comparison Of Flunisolide Nasal Spray With Combined Oral Antihistamine And Antileukotriene Therapy In Allergic Rhinitis In Relation To Patients’ Symptoms. Journal of Rawalpindi Medical College, 30(2), 252-257. https://doi.org/10.37939/jrmc.v30i2.3094

Vancouver

Batool Z, Akram CMB, Qamar SB, Khalid I, Akhtar R, Arshid F. Comparison Of Flunisolide Nasal Spray With Combined Oral Antihistamine And Antileukotriene Therapy In Allergic Rhinitis In Relation To Patients’ Symptoms. Journal of Rawalpindi Medical College. 2026;30(2):252-257. doi:10.37939/jrmc.v30i2.3094

BibTeX
@article{Batool2026,
  author = {Batool, Zahra and Akram, Ch. M. Bilal and Qamar, Saad Bin and Khalid, Inshaal and Akhtar, Rubab and Arshid, Farah},
  title = {Comparison Of Flunisolide Nasal Spray With Combined Oral Antihistamine And Antileukotriene Therapy In Allergic Rhinitis In Relation To Patients’ Symptoms},
  journal = {Journal of Rawalpindi Medical College},
  year = {2026},
  volume = {30},
  number = {2},
  pages = {252--257},
  doi = {10.37939/jrmc.v30i2.3094}
}
Kostenlos starten →